Cargando…

Is a BTKi or BCL2i preferable for first “novel” therapy in CLL? The case for BTKis

Detalles Bibliográficos
Autores principales:	Brem, Elizabeth A., O’Brien, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Point
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864648/ https://www.ncbi.nlm.nih.gov/pubmed/34965291 http://dx.doi.org/10.1182/bloodadvances.2019001204

Ejemplares similares

Is BTKi or BCL2i preferable as first novel therapy in patients with CLL? The case for BCL2i
por: Seymour, John F.
Publicado: (2022)

Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL
por: Mhibik, Maissa, et al.
Publicado: (2019)

CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL
por: Bryer, Emily, et al.
Publicado: (2022)

Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL
por: Bryer, Emily, et al.
Publicado: (2022)

Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL
por: Bryer, Emily, et al.
Publicado: (2022)

P1696: ECONOMIC BURDEN IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) FOR PATIENTS WITH ≥2 PRIOR LINES OF THERAPY INCLUDING A BRUTON TYROSINE KINASE INHIBITOR (BTKI) AND/OR B-CELL LYMPHOMA 2 INHIBITOR (BCL2I)
por: Priyadarshini, Masoom, et al.
Publicado: (2023)

Bruton’s Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials
por: Rozkiewicz, Dariusz, et al.
Publicado: (2023)

PB2696: QUALITATIVE INTERVIEWS TO DESCRIBE BURDEN IN PATIENTS (PT) WITH THIRD-LINE OR LATER CLL/SLL WITH PRIOR EXPOSURE TO BRUTON TYROSINE KINASE INHIBITOR (BTKI) AND/OR B-CELL LYMPHOMA 2 INHIBITOR (BCL2I)
por: Priyadarshini, Masoom, et al.
Publicado: (2023)

P1006: CHARACTERIZATION OF TL-895: A NOVEL BRUTON TYROSINE KINASE INHIBITOR (BTKI) IN CLINICAL DEVELOPMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MYELOFIBROSIS (MF)
por: Gulrajani, Michael, et al.
Publicado: (2023)

Primary urethral realignment should be the preferred option for the initial management of posterior urethral injuries
por: Shrinivas, R. P., et al.
Publicado: (2010)

Transobturator tapes are preferable over transvaginal tapes for the management of female stress urinary incontinence: For
por: Rajamaheshwari, N., et al.
Publicado: (2009)

PB1864: BRUIN CLL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR’S CHOICE OF IDELALISIB+RITUXIMAB OR BENDAMUSTINE+RITUXIMAB IN BTKI PRETREATED CLL/SLL (TRIAL IN PROGRESS)
por: Sharman, J. P., et al.
Publicado: (2022)

Transobturator tapes are preferable over transvaginal tapes for the management of female stress urinary incontinence: Against
por: Chawla, Arun
Publicado: (2009)

Endoscopic management is the preferred “treatment” modality for grade III vesicoureteric reflux with breakthrough infections in a young girl
por: Nerli, R. B.
Publicado: (2008)

Endoscopic management is the preferred treatment modality for a Grade III vesicoureteric reflux with breakthrough infections in a young girl
por: Joshi, S. S.
Publicado: (2008)

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation
por: Chen, Sunnia T., et al.
Publicado: (2022)

Testosterone Therapy for the Treatment of Age-Related Hypogonadism: Risks with Uncertain Benefits
por: Nguyen, Christine P., et al.
Publicado: (2021)

Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy
por: Rankin, Katherine, et al.
Publicado: (2023)

Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi
por: Zamprogna, Giulia, et al.
Publicado: (2023)

Africa rising: Opportunities for advancing theory on people, institutions, and the nation state in international business
por: Nachum, Lilac, et al.
Publicado: (2022)

Identification of six hub genes in mantle cell lymphoma patients with BTKi resistance
por: Liu, Shuozi, et al.
Publicado: (2022)

The Lighting of Wards.—I
Publicado: (1912)

Movable Kidney—I
Publicado: (1908)

The experience of UK patients with bladder cancer during the second wave of the COVID‐19 pandemic
por: Russell, Beth, et al.
Publicado: (2022)

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)
por: Al-Kali, Aref, et al.
Publicado: (2010)

Acute Retention of Urine—I
Publicado: (1908)

Should I stay or should I go: Protection and maintenance of DNA methylation at imprinted genes
por: Messerschmidt, Daniel M.
Publicado: (2012)

Hydrogen therapy may be an effective and specific novel treatment for Acute Graft-versus-host disease (GVHD)
por: Qian, Liren, et al.
Publicado: (2013)

Examination of Urine, Fæces, Etc.—I
Publicado: (1907)

As I approach the end of my life…
por: Pandya, Sunil
Publicado: (2015)

Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition
por: Lew, Thomas E., et al.
Publicado: (2021)

Zinc'ing down RNA polymerase I
por: Chanfreau, Guillaume F
Publicado: (2013)

How I Manage Complications in Aesthetic Surgery
por: Vedamurthy, Maya
Publicado: (2015)

Metabolism‐based therapies for epilepsy: new directions for future cures
por: Cervenka, Mackenzie, et al.
Publicado: (2021)

A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL
por: Jain, Nitin, et al.
Publicado: (2016)

The world economy will need even more globalization in the post-pandemic 2021 decade
por: Contractor, Farok J.
Publicado: (2021)

Neglected elements: What we should cover more of in international business research
por: Arikan, Ilgaz, et al.
Publicado: (2021)

The last frontier of globalization: Trade and foreign direct investment in healthcare
por: Shenkar, Oded, et al.
Publicado: (2021)

Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation
por: Tey, Siok-Keen, et al.
Publicado: (2022)

Charting new courses to enter foreign markets: Conceptualization, theoretical framework, and research directions on non-traditional entry modes
por: Brouthers, Keith D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v42pmao54cv5mj17hpu6ha6m5i